Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ)
| Market Cap | $3.06M-85.2% |
| Revenue (ttm) | $3.00K-50.0% |
| Net Income | -$7.47M-25.4% |
| EPS | -$1.92+34.0% |
| Shares Out | 7.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 74,892 |
| Open | $0.41 |
| Previous Close | $0.44 |
| Day's Range | $0.40 - $0.42 |
| 52-Week Range | $0.40 - $4.72 |
| Beta | 1.95 |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | Mar 19, 2027 |
About CELZ
Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Mar 19, 2027Earnings report
$CELZ stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in CELZ holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CELZ's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CELZ Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CELZ patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CELZ from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CELZ
| VXFVanguard Extended Market ETF | $13.33K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from CELZ’s recent data — informational, not investment advice
